Key Metrics of Quantum Cyber N.V.
Revenue—FY 2023
Operating income—
Net profit—
Shareholders' equity$3.4M
Market cap$89.0MQUCY · $1.02
Competitors10identified
About Quantum Cyber N.V.
Sectors
Company details
- Founded
- 2021
- Listed
- Nasdaq: QUCY (since 2021)
Operational Areas of Quantum Cyber N.V.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameQuantum Cyber N.V.
TickerQUCY
ExchangeNasdaq
CountryGermany
SEC CIK0001874252
Listed since2021
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
QUCY · Nasdaq · SEC CIK 0001874252
Last price · 24 Oct 2026
$1.02
+0.00%
Market cap$89.0M
P/E—On FY 2023 diluted EPS
Volume237,396
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOGermanyListed 2021
QUCY share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Quantum Cyber N.V.
Competitors10identified
Countries1most in Germany
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | the-odin.com | — | Solan, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | morphosys.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | curevac.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | medigene.com | — | Jaipur, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | evotec.com | 1993 | Germany | |
| Part of GSK. | glaxosmithkline.de | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | miltenyibiotec.com | — | Hyderabad, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | mwg-biotech.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | promega.com | — | Mumbai, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gatc-biotech.com | — | Germany |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.